Market Movers (8-K)
See all →NASDAQ
ALAB
Astera Labs, INCAstera Labs stockholders re-elected three Class II directors and ratified the appointment of PricewaterhouseCoopers LLP.
NASDAQ
ALAB
Astera Labs, INCAstera Labs announced record first quarter 2026 revenue of $308.4 million, a 93% increase year-over-year, driven by strong demand for its PCIe 6 AI fabric solutions.
Better than expected
NASDAQ
ALAB
Astera Labs, INCAstera Labs announced the retirement of Chief Financial Officer Michael Tate and the appointment of Desmond Lynch as his successor, effective March 2, 2026.
NASDAQ
ALAB
Astera Labs, INCAstera Labs announced record fourth-quarter revenue of $270.6 million and full-year 2025 revenue of $852.5 million, driven by strong demand for AI infrastructure connectivity solutions.
Better than expected
NASDAQ
ALAB
Astera Labs, INCAstera Labs, Inc. has entered into a new agreement with Amazon.com, Inc., granting Amazon warrants to acquire over 3.2 million shares tied to future product purchases totaling up to $6.5 billion.
Capital raise
NASDAQ
ALAB
Astera Labs, INCAstera Labs, Inc. announced the appointment of Germaine Cota as Chief Accounting Officer and Vice President of Finance, effective January 20, 2026.
Quarterly Earnings (10-Q)
See all →NASDAQ
ALAB
Astera Labs, INCAstera Labs reports robust third-quarter 2025 results with revenue more than doubling year-over-year and significant net income, despite ongoing material weaknesses in internal controls.
Better than expected
Capital raise
NASDAQ
ALAB
Astera Labs, INCAstera Labs reported robust financial results for Q2 2025, with revenue surging 150% and the company achieving net income, driven by strong demand for its AI and cloud connectivity products.
Better than expected
Capital raise
NASDAQ
ALAB
Astera Labs, INC10-Q: Astera Labs Reports Strong Q1 2025 Revenue Growth, Driven by High Demand for Connectivity Solutions
Astera Labs' Q1 2025 revenue surged by 144% year-over-year, fueled by increased demand for its Aries and Taurus products, while the company continues to address internal control weaknesses.
Better than expected
NASDAQ
ALAB
Astera Labs, INCAstera Labs experienced a significant increase in revenue and gross profit in Q3 2024, driven by strong demand for its Aries product line and the completion of its IPO.
Better than expected
NASDAQ
ALAB
Astera Labs, INCAstera Labs saw a significant increase in revenue for the second quarter of 2024, driven by strong demand for its Aries products, but also experienced a substantial rise in operating expenses due to stock-based compensation and increased headcount.
Better than expected
NASDAQ
ALAB
Astera Labs, INCAstera Labs saw a significant revenue increase in the first quarter of 2024, driven by demand for its Aries product, but also reported a substantial net loss due to increased operating expenses, including stock-based compensation related to its recent IPO.
Worse than expected
Annual Reports (10-K)
NASDAQ
ALAB
Astera Labs, INCAstera Labs reported a significant 115% revenue increase to $852.5 million in 2025, driven by strong demand for its AI and cloud connectivity solutions, achieving net income of $219.1 million.
Capital raise
Better than expected
NASDAQ
ALAB
Astera Labs, INCAstera Labs' 2024 10-K filing reveals significant revenue growth driven by AI and cloud infrastructure demand, but also highlights material weaknesses in internal controls and ongoing risks.
Delay expected
Worse than expected
Insider Trading (Form 4)
See all →NASDAQ
ALAB
Astera Labs, INCForm 4: Astera Labs COO Sells Shares
Sanjay Gajendra, President and COO and a Director of Astera Labs, Inc., sold 90,630 shares of common stock on August 17, 2026.
NASDAQ
ALAB
Astera Labs, INCPhilip Mazzara, General Counsel and Secretary of Astera Labs, Inc., sold 6,801 shares of common stock on August 17, 2026.
NASDAQ
ALAB
Astera Labs, INCForm 4: Astera Labs CEO Sells Shares
Jitendra Mohan, Chief Executive Officer and a Director of Astera Labs, Inc., sold 90,630 shares of common stock on August 17, 2026.
NASDAQ
ALAB
Astera Labs, INCStefan A Dyckerhoff, a Director of Astera Labs, Inc., sold 12,499 shares of common stock on August 6, 2026.
NASDAQ
ALAB
Astera Labs, INCGermaine Cota, Chief Accting. Off. & VP, Fin. of Astera Labs, Inc., received 1,451 shares of common stock on July 20, 2026.
NASDAQ
ALAB
Astera Labs, INCAstera Labs Director Manuel Alba has sold a significant number of shares through a pre-arranged Rule 10b5-1 trading plan, indicating a planned divestment strategy.
Proxy Statements (Def-14A)
NASDAQ
ALAB
Astera Labs, INCAstera Labs, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pertaining to Section 14(a) of the Securities Exchange Act of 1934.
NASDAQ
ALAB
Astera Labs, INCAstera Labs will hold its 2025 Annual Meeting of Stockholders on June 5, 2025, to elect directors and ratify the appointment of its independent accounting firm.
New Public Companies (S-1)
NASDAQ
ALAB
Astera Labs, INCAstera Labs, a semiconductor company focused on connectivity solutions for cloud and AI infrastructure, aims to raise approximately $517.6 million through its initial public offering.
Worse than expected
Capital raise
NASDAQ
ALAB
Astera Labs, INCAstera Labs, a semiconductor company focused on connectivity solutions for cloud and AI infrastructure, has filed for an initial public offering (IPO) to fuel its growth in the rapidly expanding market.
Capital raise
NASDAQ
ALAB
Astera Labs, INCAstera Labs, a semiconductor company focused on connectivity solutions for cloud and AI infrastructure, has filed an amended S-1 registration statement for its initial public offering (IPO).
Capital raise
NASDAQ
ALAB
Astera Labs, INCAstera Labs, a semiconductor company focused on connectivity solutions for cloud and AI infrastructure, has filed an S-1 registration statement for an initial public offering.
Worse than expected
Capital raise
Schedule 13G - Passive Investments
See all →NASDAQ
ALAB
Astera Labs, INCSCHEDULE: BlackRock Discloses Astera Labs Stake
BlackRock, Inc. has updated its Schedule 13G filing, reporting a beneficial ownership of 7.4% in Astera Labs Inc. as of June 30, 2026.
NASDAQ
ALAB
Astera Labs, INCThe Vanguard Group filed an amended Schedule 13G, reporting 0% beneficial ownership of Astera Labs Inc. Common Stock following an internal realignment.
NASDAQ
ALAB
Astera Labs, INCSCHEDULE 13G/A: BlackRock Boosts Astera Labs Stake to 6.2%
BlackRock, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 6.2% of Astera Labs Inc.'s common stock as of December 31, 2025.
NASDAQ
ALAB
Astera Labs, INCSanjay Gajendra, a U.S. citizen, has reported beneficial ownership of 4.5% of Astera Labs, Inc.'s common stock as of September 30, 2025.
NASDAQ
ALAB
Astera Labs, INCSCHEDULE: Astera Labs Insider Discloses 5.4% Stake
Jitendra Mohan, an individual, reported beneficial ownership of 5.4% of Astera Labs, Inc.'s common stock as of September 30, 2025.
NASDAQ
ALAB
Astera Labs, INCSCHEDULE 13G: BlackRock Discloses 5.02% Stake in Astera Labs
BlackRock, Inc. has reported a beneficial ownership of 5.02% of Astera Labs Inc.'s common stock, totaling 8,352,673 shares.